|
Name |
Eugenitol
|
Molecular Formula | C11H10O4 | |
IUPAC Name* |
5,7-dihydroxy-2,6-dimethylchromen-4-one
|
|
SMILES |
CC1=CC(=O)C2=C(O1)C=C(C(=C2O)C)O
|
|
InChI |
InChI=1S/C11H10O4/c1-5-3-8(13)10-9(15-5)4-7(12)6(2)11(10)14/h3-4,12,14H,1-2H3
|
|
InChIKey |
HMAUJNAGOIPKDG-UHFFFAOYSA-N
|
|
Synonyms |
EUGENITOL; 5,7-dihydroxy-2,6-dimethylchromen-4-one; 491-48-5; 5,7-dihydroxy-2,6-dimethylchromone; KBio2_001059; Spectrum_000579; SpecPlus_000031; Spectrum2_000749; Spectrum3_000183; Spectrum4_001500; Spectrum5_000239; 5,7-dihydroxy-2,6-dimethyl-4H-chromen-4-one; BSPBio_001705; KBioGR_002139; KBioSS_001059; DivK1c_006127; SPBio_000738; CHEMBL3039487; CHEBI:92806; KBio1_001071; KBio2_003627; KBio2_006195; KBio3_001205; DTXSID70407683; CCG-38991; SDCCGMLS-0066844.P001; NCGC00179070-01; 5,7-dihydroxy-2,6-dimethyl-1-benzopyran-4-one; BRD-K46068882-001-02-7; Q27164567
|
|
CAS | 491-48-5 | |
PubChem CID | 5036604 | |
ChEMBL ID | CHEMBL3039487 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 206.19 | ALogp: | 2.1 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 66.8 | Aromatic Rings: | 2 |
Heavy Atoms: | 15 | QED Weighted: | 0.694 |
Caco-2 Permeability: | -4.809 | MDCK Permeability: | 0.00001110 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.981 |
Human Intestinal Absorption (HIA): | 0.014 | 20% Bioavailability (F20%): | 0.094 |
30% Bioavailability (F30%): | 0.838 |
Blood-Brain-Barrier Penetration (BBB): | 0.016 | Plasma Protein Binding (PPB): | 91.65% |
Volume Distribution (VD): | 0.604 | Fu: | 11.64% |
CYP1A2-inhibitor: | 0.968 | CYP1A2-substrate: | 0.955 |
CYP2C19-inhibitor: | 0.17 | CYP2C19-substrate: | 0.214 |
CYP2C9-inhibitor: | 0.357 | CYP2C9-substrate: | 0.831 |
CYP2D6-inhibitor: | 0.282 | CYP2D6-substrate: | 0.584 |
CYP3A4-inhibitor: | 0.123 | CYP3A4-substrate: | 0.233 |
Clearance (CL): | 6.335 | Half-life (T1/2): | 0.771 |
hERG Blockers: | 0.017 | Human Hepatotoxicity (H-HT): | 0.058 |
Drug-inuced Liver Injury (DILI): | 0.591 | AMES Toxicity: | 0.478 |
Rat Oral Acute Toxicity: | 0.112 | Maximum Recommended Daily Dose: | 0.803 |
Skin Sensitization: | 0.877 | Carcinogencity: | 0.104 |
Eye Corrosion: | 0.057 | Eye Irritation: | 0.946 |
Respiratory Toxicity: | 0.317 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001495 | 0.694 | D06GCK | 0.380 | ||||
ENC006031 | 0.694 | D04AIT | 0.342 | ||||
ENC001622 | 0.667 | D0FA2O | 0.338 | ||||
ENC004732 | 0.593 | D0G4KG | 0.329 | ||||
ENC002207 | 0.593 | D0K8KX | 0.316 | ||||
ENC001617 | 0.592 | D0N0OU | 0.269 | ||||
ENC004786 | 0.577 | D0Y7PG | 0.253 | ||||
ENC001940 | 0.569 | D0O6KE | 0.247 | ||||
ENC001417 | 0.534 | D07MGA | 0.247 | ||||
ENC003878 | 0.534 | D0G5UB | 0.235 |